@FierceMedDev: Histogenics files for IPO, as Autogenomics refiles again. Article | Follow @FierceMedDev
@VarunSaxena2: HillaryClinton says we have to review +s and -s of device tax. An expected non-answer. | Follow @VarunSaxena2
@EmilyWFierce: Third time's a charm? FDA panel recommends Boston Scientific's Watchman device by a slim margin. More from the WSJ | Follow @EmilyWFierce
@MichaelGFierce: With $RHHBY's Herceptin, green tea component doubles drug accumulation in #cancer cells. More | Follow @MichaelGFierce
> Becton Dickinson ($BDX) failed in its bid to overturn a $113.5 million antitrust verdict in favor Retractable Technologies ($RVP) overturned. The case was reviewed by Texas federal judge and regards safety syringe technology. Story
> The U.S. Department of Defense awarded a total of $78 million to med tech companies including Aethlon Medical, InfraScan, 3M, CAE Healthcare and Spacelabs Medical. More
> The women's healthcare unit of The Cooper Companies ($COO) acquired disposable hysteroscope maker EndoSee for $44 million. Release
> NeuroSigma postponed its IPO to raise $50 million, which was slated for yesterday, citing poor market conditions. The neuromodulation company has a device for drug-resistant epilepsy and depression. Release
Biotech News
@FierceBiotech: VC giant NEA recruits a biotech vet to join its ranks of dealmakers. Report | Follow @FierceBiotech
@JohnCFierce: Biotechs tap a swelling tide of investment cash to fund growing R&D ops--or, laissez les bon temps rouler. Story | Follow @JohnCFierce
@DamianFierce: Deal: $AUXL leaves $QLTI at the altar and accepts a $2.6B offer from $ENDP. Release | Follow @DamianFierce
@EmilyMFierce: Ebola genome browser launched to aid drug discovery. FierceBiotech Research story | Follow @EmilyMFierce
> Auxilium takes money, runs from inversion with $2.6B Endo deal. Report
> Shire's long-delayed ADHD drug hits another FDA speed bump. Article
Pharma News
@FiercePharma: Top-read in FP Weds: Novartis, GSK shake up executive ranks as overhaul continues. Article | Follow @FiercePharma
@CarlyHFierce: ICYMI, this week's issue of FiercePharmaMarketing is here. And you can subscribe here. | Follow @CarlyHFierce
> Merck can't sidestep $250M gender-bias suit, judge says. Story
> Auxilium dumps QLT inversion deal for $2.6B Endo buyout. Article
Vaccines News
> Pfizer's meningitis B vaccine is effective when given with HPV jab. More
> Sanofi bird flu vax prompts immune response in PhII--but only with Novartis adjuvant. Story
> Biotechs angling for T-cell response in race for next-gen herpes vaccine. Article
> Takeda appoints new vax development head as Novartis' Oswald heads for the door. Report
> Could 'space bacteria' help create vaccines? Item
Pharma Manufacturing News
> Impax says $700M deal for Tower will help it deal with quality issues. More
> Hospira recalls drug because of storage glitch during shipping. Report
> France's Ceva has completed a sterile facility for vet drugs. Item
> Gerresheimer adjusts earnings forecast lower in wake of FDA crackdown. Article
> CSL announces $450M commitment to expand two of its plants. Story